Second Chance for 23andMe

Is 23andMe's test likely to lead to unnecessary follow-up procedures? One writer says no.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Nature has a similar opinion

Nature has a similar opinion (one that I agree with):

FDA is stepping in way too

FDA is stepping in way too early here.
Many people are barely starting to find out about it and try it out.
People should be free to access their own genomes
and use whatever information is available.
The FDA should not squash DTC genomics before it can even flower!

Because 23andMe lacks

Because 23andMe lacks accreditation, the FDA's position is warranted without question. Sadly, the FDA's haphazard enforcement strategies are here to stay. Stop treating the systems and create a federal standard for labs to follow.